Reuters logo
BRIEF-Novus Therapeutics Inc reported Q3 $0.43 loss per share​
November 8, 2017 / 10:19 PM / 10 days ago

BRIEF-Novus Therapeutics Inc reported Q3 $0.43 loss per share​

Nov 8 (Reuters) - Novus Therapeutics Inc

* Novus Therapeutics Inc - ‍for Q3 of 2017, Novus reported $0.43 loss per share​ Source text: (bit.ly/2hldAkp) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below